Open access · OA
via OpenAlex
Emerging potential benefits of modulating NAD + metabolism in cardiovascular disease
Daniel S. Matasic, Charles Brenner, Barry London
American Journal of Physiology-Heart and Circulatory Physiology · 2017 · ▲ 65 citations
Genomic instability
Deregulated nutrient-sensing
Altered intercellular communication
Human
Preclinical / animal
Review
Abstract
Nicotinamide adenine dinucleotide (NAD + ) and related metabolites are central mediators of fuel oxidation and bioenergetics within cardiomyocytes. Additionally, NAD + is required for the activity of multifunctional enzymes, including sirtuins and poly(ADP-ribose) polymerases that regulate posttranslational modifications, DNA damage responses, and Ca 2+ signaling. Recent research has indicated that NAD + participates in a multitude of processes dysregulated in cardiovascular diseases. Therefore, supplementation of NAD + precursors, including nicotinamide riboside that boosts or repletes the NAD + metabolome, may be cardioprotective. This review examines the molecular physiology and preclinical data with respect to NAD + precursors in heart failure-related cardiac remodeling, ischemic-reperfusion injury, and arrhythmias. In addition, alternative NAD + -boosting strategies and potential systemic effects of NAD + supplementation with implications on cardiovascular health and disease are surveyed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1152/ajpheart.00409.2017
- Canonical
- link ↗
- Fetched
- 2026-08-25 MST
Cite this
APA
Matasic, D.S., Brenner, C., & London, B. (2017). Emerging potential benefits of modulating NAD + metabolism in cardiovascular disease. <em>American Journal of Physiology-Heart and Circulatory Physiology</em>. https://doi.org/10.1152/ajpheart.00409.2017
Vancouver
Matasic DS, Brenner C, London B. Emerging potential benefits of modulating NAD + metabolism in cardiovascular disease. American Journal of Physiology-Heart and Circulatory Physiology. 2017. doi:10.1152/ajpheart.00409.2017.
BibTeX
@article{daniel2017Emergi,
title = {Emerging potential benefits of modulating NAD + metabolism in cardiovascular disease},
author = {Daniel S. Matasic and Charles Brenner and Barry London},
journal = {American Journal of Physiology-Heart and Circulatory Physiology},
year = {2017},
doi = {10.1152/ajpheart.00409.2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nutrition & Metabolism 2022
Open access · CC-BY
Effects of NAD+ precursor supplementation on glucose and lipid metabolism in humans: a meta-analysis
Current Opinion in Cardiology 2026
Citation only
Role of nicotinamide adenine dinucleotide in cardiovascular disease
Current opinion in cardiology 2026
Citation only
Role of nicotinamide adenine dinucleotide in cardiovascular disease.
Antioxidants and Redox Signaling 2023
Citation only
NAD + Precursors in Human Health and Disease: Current Status and Future Prospects
2016
Preprint · OA
Novel NAD+ metabolomic technologies and their applications to Nicotinamide Riboside interventions
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics 2020
Open access · OA